Your search returned 11 studies. (Get alerts for new studies):
- Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
Conditions: Waldenstrom Macroglobulinemia
1 Location available
- Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
Conditions: Waldenstrom's Macroglobulinemia
1 Location available
- A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic
Conditions: Lymphoma, Mantle-Cell - Leukemia, Lymphocytic, Chronic, B-Cell - Leukemia, Hairy Cell - Waldenstrom Macroglobulinemia - Multiple Myeloma
1 Location available
- Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Conditions: Multiple Myeloma - Waldenstrom's Macroglobulinemia - Smoldering Multiple Myeloma - Lymphoblastic Lymphoma
1 Location available
- Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
Conditions: Waldenstrom's Macroglobulinemia
1 Location available
- Dose Escalation Study of INK128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia
Conditions: Relapsed or Refractory Multiple Myeloma - Waldenstrom Macroglobulinemia
4 Locations available
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobul
Conditions: B Cell Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Waldenstrom Macroglobulinemia
13 Locations available
- Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia
Conditions: Waldenstrom's Macroglobulinemia
1 Location available
- Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or
Conditions: Cognitive/Functional Effects - Fatigue - Lymphoma - Neurotoxicity - Therapy-related Toxicity
6 Locations available
- TLR8 Agonist VTX-2337 in Combo With Local Radiation in Low-Grade B-cell Lymphomas
Conditions: Lymphoma, Non-Hodgkin - Cutaneous Lymphoma - Large B Cell Diffuse Lymphoma - Mantle Cell Lymphoma - Marginal Zone B-Cell Lymphoma - Peripheral T-cell Lymphoma, Large Cell - Waldenstrom Macroglobulinemia
1 Location available
- Phase 1 Study of Oral MLN9708 in Patients With Advanced Nonhematologic Malignancies or Lymphoma
Conditions: Lymphoma - Waldenstrom's Macroglobulinemia - Nonhematologic Malignancies
5 Locations available
|